Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Molecular Partners AG
Research & Development Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Research & Development
-CHf63.3m
CAGR 3-Years
0%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Research & Development
-$127.1m
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Research & Development
-CHf59.4m
CAGR 3-Years
0%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Research & Development
-$333.6m
CAGR 3-Years
5%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Research & Development
-CHf90m
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
-5%
Kuros Biosciences AG
SIX:KURN
Research & Development
-CHf6.9m
CAGR 3-Years
-27%
CAGR 5-Years
1%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Research & Development?
Research & Development
-63.3m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Research & Development amounts to -63.3m CHF.

What is Molecular Partners AG's Research & Development growth rate?
Research & Development CAGR 5Y
-10%

Over the last year, the Research & Development growth was 12%.

Back to Top